These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9522486)

  • 21. [Study on short-term therapeutic effect and its impact factors of stereotactic surgery for treating opiate users with opiate dependence in Sichuan].
    Zhang B; Liao J; Wang ZR; Chen Y; Gu JW; Chen LG; Fang J
    Wei Sheng Yan Jiu; 2006 Sep; 35(5):599-603. PubMed ID: 17086714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.
    Bell J; Burrell T; Indig D; Gilmour S
    Drug Alcohol Depend; 2006 Jan; 81(1):55-61. PubMed ID: 15993552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized control trial of group counseling in a naltrexone treatment program.
    Tucker T; Ritter A; Maher C; Jackson H
    J Subst Abuse Treat; 2004 Dec; 27(4):277-88. PubMed ID: 15610829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The results of drug dependence treatment by therapeutic community in Thanyarak Institute on Drug Abuse.
    Verachai V; Punjawatnun J; Perfas F
    J Med Assoc Thai; 2003 May; 86(5):407-14. PubMed ID: 12859095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Group hypnosis treatment of drug addicts].
    Kaminsky D; Rosca P; Budowski D; Korin Y; Yakhnich L
    Harefuah; 2008; 147(8-9):679-83, 751. PubMed ID: 18935753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
    Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Young heroin users in Baltimore: a qualitative study.
    Gandhi DH; Kavanagh GJ; Jaffe JH
    Am J Drug Alcohol Abuse; 2006; 32(2):177-88. PubMed ID: 16595322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts.
    Gerra G; Bertacca S; Zaimovic A; Pirani M; Branchi B; Ferri M
    Subst Use Misuse; 2008; 43(3-4):317-30. PubMed ID: 18365934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence.
    Degenhardt L; Conroy E; Day C; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Aug; 79(2):129-35. PubMed ID: 16002022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan.
    Chiang SC; Chan HY; Chang YY; Sun HJ; Chen WJ; Chen CK
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):105-11. PubMed ID: 17239047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
    Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
    Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic communities for drug addicts: prediction of long-term outcomes.
    Dekel R; Benbenishty R; Amram Y
    Addict Behav; 2004 Dec; 29(9):1833-7. PubMed ID: 15530725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.